Evolution of naturally arising SARS-CoV-2 defective interfering particles

[1]  R. Andino,et al.  A defective viral genome strategy elicits broad protective immunity against respiratory viruses , 2021, Cell.

[2]  L. Weinberger,et al.  Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance , 2021, Cell.

[3]  A. Banerjee,et al.  Molecular Determinants of SARS-CoV-2 Variants , 2021, Trends in Microbiology.

[4]  I. Ulitsky,et al.  SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis , 2021, Nature.

[5]  M. Vignuzzi,et al.  Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts , 2021, Nature Communications.

[6]  M. Vignuzzi,et al.  Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes , 2021, PLoS pathogens.

[7]  J. Minna,et al.  Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression , 2021, Science Advances.

[8]  R. Andino,et al.  Experimental and mathematical insights on the interactions between poliovirus and a defective interfering genome , 2021, bioRxiv.

[9]  Christopher P. Lapointe,et al.  Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation , 2020, Proceedings of the National Academy of Sciences.

[10]  M. Archetti,et al.  A synthetic defective interfering SARS-CoV-2 , 2020, bioRxiv.

[11]  E. Westhof,et al.  The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation , 2020, bioRxiv.

[12]  N. Ban,et al.  SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation , 2020, Nature Structural & Molecular Biology.

[13]  S. Perlman,et al.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis , 2020, Methods in molecular biology.

[14]  Y. Xiong,et al.  Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA , 2020, bioRxiv.

[15]  E. Miska,et al.  The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2 , 2020, bioRxiv.

[16]  Bader Y. Alhatlani.  In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome , 2020, bioRxiv.

[17]  Thomas Becker,et al.  Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 , 2020, Science.

[18]  A. Pruijssers,et al.  The coronavirus proofreading exoribonuclease mediates extensive viral recombination , 2020, bioRxiv.

[19]  Joy Y. Feng,et al.  Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency , 2020, The Journal of Biological Chemistry.

[20]  Hyeshik Chang,et al.  The Architecture of SARS-CoV-2 Transcriptome , 2020, Cell.

[21]  Bao Zhang,et al.  The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms , 2019, Front. Microbiol..

[22]  Krishna Shankara Narayanan,et al.  SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage , 2011, PLoS pathogens.

[23]  Hideaki Sugawara,et al.  The Sequence Read Archive , 2010, Nucleic Acids Res..

[24]  Shinji Makino,et al.  A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein , 2009, Nature Structural &Molecular Biology.

[25]  N. Dimmock,et al.  Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral , 2008, Journal of Virology.

[26]  D. Brian,et al.  An RNA Stem-Loop within the Bovine Coronavirus nsp1 Coding Region Is a cis-Acting Element in Defective Interfering RNA Replication , 2007, Journal of Virology.

[27]  C. J. Bennett,et al.  A Hypervariable Region within the 3′ cis-Acting Element of the Murine Coronavirus Genome Is Nonessential for RNA Synthesis but Affects Pathogenesis , 2006, Journal of Virology.

[28]  D. Brian,et al.  Common RNA replication signals exist among group 2 coronaviruses: evidence for in vivo recombination between animal and human coronavius molecules , 2003, Virology.

[29]  D. Brian,et al.  Stem-Loop III in the 5′ Untranslated Region Is a cis-Acting Element in Bovine Coronavirus Defective Interfering RNA Replication , 2003, Journal of Virology.

[30]  D. Brian,et al.  A Phylogenetically Conserved Hairpin-Type 3′ Untranslated Region Pseudoknot Functions in Coronavirus RNA Replication , 1999, Journal of Virology.

[31]  A. Izeta,et al.  Replication and Packaging of Transmissible Gastroenteritis Coronavirus-Derived Synthetic Minigenomes , 1999, Journal of Virology.

[32]  S. Evans,et al.  Sequence elements involved in the rescue of IBV defective RNA CD-91. , 1998, Advances in experimental medicine and biology.

[33]  V. Thiel,et al.  Replication and transcription of HCV 229E replicons. p6. , 1998, Advances in experimental medicine and biology.

[34]  M. Lai,et al.  The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA , 1996, Journal of virology.

[35]  D. Brian,et al.  cis Requirement for N-specific protein sequence in bovine coronavirus defective interfering RNA replication , 1996, Journal of virology.

[36]  F. Gebauer,et al.  Molecular Characterization of Transmissible Gastroenteritis Coronavirus Defective Interfering Genomes: Packaging and Heterogeneity , 1996, Virology.

[37]  S. Makino,et al.  Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal , 1995, Journal of virology.

[38]  N. Dimmock,et al.  Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs. , 1995, Virology.

[39]  D. Brian,et al.  A cis-acting function for the coronavirus leader in defective interfering RNA replication , 1994, Journal of virology.

[40]  P. Britton,et al.  Characterization of a Replicating and Packaged Defective RNA of Avian Coronavirus Infectious Bronchitis Virus , 1994, Virology.

[41]  M. Lai,et al.  Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication , 1993, Journal of virology.

[42]  M. Lai,et al.  Generation and Selection of Coronavirus Defective Interfering RNA with Large Open Reading Frame by RNA Recombination and Possible Editing , 1993, Virology.

[43]  M. Lai,et al.  Natural Evolution of Coronavirus Defective-Interfering RNA Involves RNA Recombination , 1993, Virology.

[44]  W. Spaan,et al.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs , 1991, Journal of virology.

[45]  M. Lai,et al.  Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal , 1990, Journal of virology.

[46]  M. Lai,et al.  Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs , 1988, Virology.

[47]  S. Makino,et al.  Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus , 1985, Journal of virology.

[48]  A. Huang,et al.  Cyclic production of vesicular stomatitis virus caused by defective interfering particles. , 1974, The Journal of infectious diseases.